{{Chembox
| ImageFile = Cetamolol.svg
| ImageSize = 200px
| ImageAlt = 
| IUPACName = 2-[2-[3-(''tert''-Butylamino)-2-hydroxypropoxy]phenoxy]-''N''-methylacetamide
| OtherNames = 
|Section1={{Chembox Identifiers
| CASNo = 77590-95-5 
| CASNo_Comment = (hydrochloride)
| PubChem = 53698
| ChemSpiderID = 48483
| ChEMBL = 2105989
| InChI=1S/C16H26N2O4/c1-16(2,3)18-9-12(19)10-21-13-7-5-6-8-14(13)22-11-15(20)17-4/h5-8,12,18-19H,9-11H2,1-4H3,(H,17,20)
| InChIKey= UWCBNAVPISMFJZ-UHFFFAOYSA-N
| SMILES = CC(C)(C)NCC(COC1=CC=CC=C1OCC(=O)NC)O}}
|Section2={{Chembox Properties
| C=16 | H=26 | N=2 | O=4
| Appearance = 
| Density = 
| MeltingPt = 
| BoilingPt = 
| Solubility = }}
|Section3={{Chembox Hazards
| MainHazards = 
| FlashPt = 
| AutoignitionPt = }}
}}

'''Cetamolol''' is a [[beta adrenergic antagonist]].<ref>{{cite journal|pmid=2905711|year=1988|last1=Klausner|first1=MA|last2=Irwin|first2=C|last3=Mullane|first3=JF|last4=Shand|first4=DG|last5=Leese|first5=PT|last6=Arnold|first6=JD|last7=Wollberg|first7=W|last8=Wagner|first8=NB|last9=Wagner|first9=GS|title=Effect of cetamolol on epinephrine-induced hypokalemia|volume=28|issue=8|pages=751â€“6|journal=Journal of clinical pharmacology|doi=10.1002/j.1552-4604.1988.tb03210.x}}</ref>

==Synthesis==
Cardioselective b1-adrenergic blocker. 
[[File:Cetamolol synthesis.svg|thumb|center|700px|Cetamolol synthesis:<ref>HL Tucker, {{Cite patent|DE|2453324}} (1975) via Chem. Abstr., 83:96,993p</ref><ref>{{Cite patent|BE|767781}}; D. J. Lecount, C. J. Squire, {{US patent|4059622}} (1971, 1977 both to ICI).</ref>]]

==References==
{{reflist}}


{{Adrenergics}}

{{organic-compound-stub}}
{{pharma-stub}}

[[Category:Beta blockers]]